Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research into type 2 diabetes treatment. This peptide shows superior efficacy in glucose control and weight management compared to selective GLP-1 agonists.
The molecular structure of tirzepatide features a PEG-modified lysine side chain that enhances water solubility. As a dual agonist, it demonstrates greater affinity for GIP receptors while maintaining significant GLP-1 receptor activity. Clinical research indicates potential applications in metabolic disorders and weight management.
Our tirzepatide is supplied as white powder in sealed vials with 99.9% purity. The product is strictly for research purposes and not intended for human consumption. Researchers looking where to buy tirzepatide can find reliable quantities from 10mg to bulk orders.
Storage conditions are critical for maintaining peptide integrity. We recommend storing tirzepatide in a cool, dark environment and avoiding repeated freeze-thaw cycles. Proper handling ensures optimal performance in research applications.
For researchers investigating metabolic pathways or developing new therapeutic approaches, tirzepatide offers unique dual-receptor activity. Its mechanism of action combines the benefits of both GIP and GLP-1 receptor activation in a single molecule.